Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) Operating cash flow
Henry Schein, Inc.'s operating cash flow for fiscal 2025 was $712.0M, down 16.0% from $848.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $700.0M. Over the past ten years it has ranged from $500.0M (fiscal 2023) to $848.0M (fiscal 2024); the current reading is higher than 91% of that period. Henry Schein, Inc. ranks 4th of 11 Medical Distribution companies by operating cash flow.
Operating cash flow, annual
Annual
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $712.0M | (16.04%) |
| FY2024 | $848.0M | 69.60% |
| FY2023 | $500.0M | (16.94%) |
| FY2022 | $602.0M | (15.21%) |
| FY2021 | $710.0M | 18.53% |
| FY2020 | $599.0M | (8.42%) |
| FY2019 | $654.1M | (4.47%) |
| FY2018 | $684.7M | 25.52% |
| FY2017 | $545.5M | (15.10%) |
| FY2016 | $642.6M | 4.40% |
Quarterly
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $242.0M | — |
| Mar 2026 | −$97.0M | — |
| Dec 2025 | $381.0M | 118.97% |
| Sep 2025 | $174.0M | 45.00% |
| 42 more quarters | Free account |
Against its own ten years
Low $500.0M
High $848.0M
Ten-year median
$642.6M
Current reading's percentile
91
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| MCK McKesson Corporation compare | $6.9B |
| CAH Cardinal Health, Inc. compare | $5.2B |
| COR Cencora, Inc. compare | $4.8B |
| HSIC Henry Schein, Inc. | $700.0M |
| AHG Akso Health Group Sponsored ADR compare | −$5.3M |
| COSM Cosmos Health Inc. compare | −$9.8M |
| YI 111, Inc. Sponsored ADR compare | −$11.8M |
| FOCL FocalTherics compare | −$13.0M |
| ACH Accendra Health, Inc. compare | −$180.4M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement